Clorox Healthcare, along with Ultraviolet Devices, has introduced new Optimum-UV Enlight System, which holds capability to kill 31 pathogens.

Clorox

The new system features enhanced UV technology with advanced data collection and reporting capabilities, clinically proven efficacy and affordability to enable facility-wide adoption.

Clorox Healthcare scientist Dr Katherine Velez said: "We know that environmental services and infection control professionals are looking for more efficient and easy-to-use ways to implement UV devices and track infection rates across their facilities, which can be a time-intensive process.

"The Optimum-UV Enlight System’s smart data capabilities help do the heavy lifting to improve infection control processes and minimize workflow challenges so that UV can be seamlessly integrated into larger environmental infection control practices."

The Optimum-UV Enlight System is said to kill a total of 31 pathogens in five minutes at a distance of 8ft, including a 4-log reduction of Clostridium difficile (C. difficile) spores.

It can also kill pathogens with a greater than 5-log reduction of more than 20 pathogens such as methicillin- resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) and carbapenem-resistant Enterobacteriaceae (CRE).

The system will track device usage across rooms, locations and operators, providing automated reporting, which is accessible in real time.

It also offers diagnostic data with automated alerts to inform users about maintenance needs and helps to identify areas for targeted staff training.

The enhanced interface includes more data storage and a large, easy-to-use color touchscreen that allows users to manage rooms, locations and operators for reporting analytics.

The company is showcasing the system at the Association for the Healthcare Environment (AHE) EXCHANGE 2015 annual conference, which is being held from 20 to 23 September.


Image: The Clorox Healthcare Optimum-UV Enlight System. Photo: courtesy of PRNewswire/ Clorox Healthcare.